通过开发药物纳米微粒配方来增强ezetimibe的抗癌活性:由分子对接支持的有希望的战略
Tarek A Ahmed1, Ehab M M Ali2, Abdelsattar M Omar3
1Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Kingdom of Saudi Arabia.
International journal of nanomedicine
|November 29, 2023
概括
这项研究开发了ezetimibe (F5) 的纳米粒,以增强其抗癌性质. F5配方显著增加了乳腺癌细胞中的细胞毒性和亡,表明其作为有效的药物递送系统的潜力.
科学领域:
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 一种降胆固醇药物埃泽蒂米布 (ezetimibe) 显示出潜在的抗癌活性.
- 新的纳米配方正在探索,以提高ezetimibe对抗癌症的疗效.
研究的目的:
- 为改善抗癌效果开发和表征以泽提比纳米细胞.
- 评估纳米配方对乳腺癌细胞的细胞毒性,细胞亡和细胞周期影响.
主要方法:
- 使用TPGS和Pluronic F127.7来制备和表征15种纳米微粒配方.
- 形态分析,分子对接和细胞活性的体外评估,细胞亡和细胞周期.
- 评估埃泽胺的捕获效率 (EE) 和IC50值.
主要成果:
- 基于TPGS的纳米微粒 (F5) 表现出高的ezetimibe EE (94.03%) 和最佳的纳米尺寸特征.
- 分子对接揭示了ezetimibe和Interleukin-1β转化酶之间有利的相互作用.
- F5对MCF-7和T47D细胞显示显著较低的IC50值,诱导了细胞亡和细胞循环停止.
结论:
- 开发的基于TPGS的纳米小细胞配方 (F5) 有效地增强了ezetimibe对乳腺癌的细胞毒性活性.
- 作为一种药物输送系统,F5显示出增强ezetimibe在瘤学中的治疗潜力的前景.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


